The effects of whole body vibration training on muscle function and bone density in children and adolescents with cerebral palsy.

Dr Paul Hofman0 sites60 target enrollmentMay 5, 2011

Overview

No summary available.

Registry

who.int

Start Date

May 5, 2011

End Date

July 10, 2019

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

Dr Paul Hofman

•Children and adolescents with cerebral palsy (GMFCS II, III and IV) aged between 8 and 20 years. To be included in the study participants must be able to stand on vibration platform and be able to undertake evaluation of the therapy.

•Participants will be excluded if: 1\) they have a fracture of any type within 8 weeks of enrollment, pregnancy and acute thrombosis, muscle or tendom inflammation, renal stones, discopathy or arthritis. 2\) there is history of clinically significant organic disease or findings on physical examination, which in the opinion of the investigator would prevent the patient from completing the study. 3\) There is history of using any of the following medications, regardless of dose, for at least 1 month, within 3 months of enrollment: anabolic agents, glucocorticoids (does not include inhaled glucocorticoids) or growth hormone. 4\) serum 25\-hydroxyvitamin D \< 50mmol/L 5\) received Botulinium toxin injection into lower limbs within 3 months of enrollment. Participants will not receive Botolinium toxin injection throughout duration of the study.